B-cell function in severe combined immunodeficiency after stem cell or gene therapy: a review

Area of Science:

• Immunology
• Hematology
• Pediatric Medicine

Background:

• Bone marrow transplantation (BMT) is crucial for T-cell reconstitution in severe combined immunodeficiency (SCID).
• B-cell function recovery post-BMT in SCID patients is often suboptimal, necessitating further interventions.

Purpose of the Study:

• To review B-cell reconstitution outcomes in SCID patients following BMT.
• To analyze the impact of pretransplantation conditioning regimens on B-cell recovery and overall survival.

Main Methods:

• Systematic review of 19 reports from the US and Europe on post-BMT immune reconstitution in SCID over two decades.
• Analysis of pretransplantation conditioning, survival rates, B-cell chimerism and function, and immunoglobulin replacement needs.

Main Results:

• Centers avoiding pretransplantation conditioning showed higher survival rates.
• Centers using pretransplantation conditioning reported better B-cell chimerism and function, with lower immunoglobulin replacement rates.
• Significant numbers of patients required immunoglobulin replacement regardless of conditioning, indicating incomplete B-cell recovery.

Conclusions:

• Pretransplantation conditioning improves B-cell reconstitution in SCID but does not ensure complete functional recovery.
• The decision to use conditioning agents involves balancing potential B-cell benefits against risks of compromised innate immunity and toxicity.
• Further research is needed to optimize B-cell immune reconstitution strategies in SCID patients.